77 related articles for article (PubMed ID: 1966941)
1. Combination of mutant EL-4 thymoma cells and EBV-infection in B lymphocyte activation a) EBV-infection of EL-4-activated lymphocytes. b) Use of EL-4 cells as feeders for lymphoblastoid cell lines.
Barcellini W; Borghi MO; Nicoletti F; Bonara P; Fain C; Meroni PL
J Clin Lab Immunol; 1990 Sep; 33(1):21-8. PubMed ID: 1966941
[TBL] [Abstract][Full Text] [Related]
2. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
Straub C; Zubler RH
J Immunol; 1989 Jan; 142(1):87-93. PubMed ID: 2535862
[TBL] [Abstract][Full Text] [Related]
3. Soluble factor-independent stimulation of human B cell response by mouse thymoma cells. Cyclosporine A-resistant and -sensitive cell contact signals.
Zhang XH; Hauser C; Zubler RH
J Immunol; 1990 Apr; 144(8):2955-60. PubMed ID: 2139073
[TBL] [Abstract][Full Text] [Related]
4. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
Zubler RH; Erard F; Lees RK; Van Laer M; Mingari C; Moretta L; MacDonald HR
J Immunol; 1985 Jun; 134(6):3662-8. PubMed ID: 3886789
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
J Surg Res; 2009 May; 153(1):156-61. PubMed ID: 18486150
[TBL] [Abstract][Full Text] [Related]
6. Similar CD40 ligand expression on EL-4 thymoma cell lines with widely different helper activity for B lymphocytes.
Werner-Favre C; Gauchat JF; Mazzei G; Aubry JP; Bonnefoy JY; Zubler RH
Immunology; 1994 Jan; 81(1):111-4. PubMed ID: 7510662
[TBL] [Abstract][Full Text] [Related]
7. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
8. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
10. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
[TBL] [Abstract][Full Text] [Related]
11. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
12. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
13. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma.
Lotz M; Tsoukas CD; Fong S; Carson DA; Vaughan JH
Eur J Immunol; 1985 May; 15(5):520-5. PubMed ID: 2581792
[TBL] [Abstract][Full Text] [Related]
15. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
17. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
Rousset F; Billaud M; Blanchard D; Figdor C; Lenoir GM; Spits H; De Vries JE
J Immunol; 1989 Sep; 143(5):1490-8. PubMed ID: 2547869
[TBL] [Abstract][Full Text] [Related]
18. Human B lymphoblastoid cell lines provide an interleukin 1-like signal for mitogen-treated T lymphocytes via direct cell contact.
Arnold A; Lipkowitz S; Suthanthiran M; Novogrodsky A; Stenzel KH
J Immunol; 1985 Jun; 134(6):3876-81. PubMed ID: 2985701
[TBL] [Abstract][Full Text] [Related]
19. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin.
Ranjan D; Johnston TD; Reddy KS; Wu G; Bondada S; Chen C
J Surg Res; 1999 Nov; 87(1):1-5. PubMed ID: 10527697
[TBL] [Abstract][Full Text] [Related]
20. A mechanism of T cell regulation of Epstein-Barr virus latency.
Frugoni P; Pike SE; Tosato G
Cell Immunol; 1993 Apr; 147(2):256-66. PubMed ID: 8095857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
